Xbrane Biopharma AB (STU:7XB) Days Payable : 47.63 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Xbrane Biopharma AB Days Payable?

Xbrane Biopharma AB's average Accounts Payable for the three months ended in Dec. 2023 was €2.93 Mil. Xbrane Biopharma AB's Cost of Goods Sold for the three months ended in Dec. 2023 was €5.61 Mil. Hence, Xbrane Biopharma AB's Days Payable for the three months ended in Dec. 2023 was 47.63.

The historical rank and industry rank for Xbrane Biopharma AB's Days Payable or its related term are showing as below:

STU:7XB' s Days Payable Range Over the Past 10 Years
Min: 48.69 Med: 497.5 Max: 143974.7
Current: 59.23

During the past 11 years, Xbrane Biopharma AB's highest Days Payable was 143974.70. The lowest was 48.69. And the median was 497.50.

STU:7XB's Days Payable is ranked worse than
69.87% of 717 companies
in the Biotechnology industry
Industry Median: 147.46 vs STU:7XB: 59.23

Xbrane Biopharma AB's Days Payable declined from Dec. 2022 (32,282.95) to Dec. 2023 (47.63). It may suggest that Xbrane Biopharma AB accelerated paying its suppliers.

Xbrane Biopharma AB Days Payable Historical Data

The historical data trend for Xbrane Biopharma AB's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xbrane Biopharma AB Days Payable Chart

Xbrane Biopharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

525.83

160,313.21

49.06

Xbrane Biopharma AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															32,282.95	62.47	87.95	59.36	47.63

Competitive Comparison of Xbrane Biopharma AB's Days Payable

For the Biotechnology subindustry, Xbrane Biopharma AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xbrane Biopharma AB's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xbrane Biopharma AB's Days Payable distribution charts can be found below:

* The bar in red indicates where Xbrane Biopharma AB's Days Payable falls into.

Xbrane Biopharma AB Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Xbrane Biopharma AB's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (2.119	+	2.769)	/	2 )	/	18.184	*	365
=	2.444					/	18.184	*	365
=	49.06

Xbrane Biopharma AB's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (3.085	+	2.769)	/	2 )	/	5.607	*	365 / 4
=	2.927					/	5.607	*	365 / 4
=	47.63

Xbrane Biopharma AB Days Payable Related Terms

Thank you for viewing the detailed overview of Xbrane Biopharma AB's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Xbrane Biopharma AB (STU:7XB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xbrane Biopharma AB (STU:7XB) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

XBRANE:Sweden 7XB:Germany

Address

Retzius vag 8, Solna, SWE, 171 65

Website

https://www.xbrane.com

Xbrane Biopharma AB is a biotechnology company that develops biosimilars. The company has a patented protein production platform with up to 12 times greater productivity than standard systems for the production of proteins in E.coli host cells. Xbrane's leading product candidate is Ximluci, a ranibizumab biosimilar (original drug Lucentis) used in the treatment of various eye diseases, mainly the wet form of age-related macular degeneration. The company's geographical segments include the Middle East, Asia, Europe, and the United States.

Xbrane Biopharma AB (STU:7XB) Headlines

No Headlines